Development of responder definitions for fibromyalgia clinical trials
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Objective: To develop responder definitions for fibromyalgia (FM) clinical trials using key symptom and function domains. Methods: Twenty‐four candidate responder definitions were developed by expert consensus and were evaluated in 12 randomized, placebo‐controlled trials of 4 medications for the treatment of FM. For each definition, the treatment effects of the medication compared with placebo were analyzed using Cochran‐Mantel‐Haenszel tests or chi‐square tests. A meta‐analysis of the pooled results for the 4 medications established risk ratios to determine the definitions that best favored medication over placebo. Results: Two definitions performed best in the analyses. Both definitions included ≥30% reduction in pain and ≥10% improvement in physical function. The definitions differed in that one (≥30% improvement in FM [FM30] short version) included ≥30% improvement in sleep or fatigue, and the other (FM30 long version) required ≥30% improvement in 2 of the following symptoms: sleep, fatigue, depression, anxiety, or cognition. In the analysis of both versions, the response rate was ≥15% for each medication and was significantly greater compared with placebo. The risk ratio favoring drug over placebo in the pooled analysis for FM30 version 3 (short version) was 1.50 (95% confidence interval [95% CI] 1.24–1.82; P ≤ 0.0001); the risk ratio for FM30 version 6 (long version) was 1.60 (95% CI 1.31–1.96; P ≤ 0.00001). Conclusion: Among the 24 responder definitions tested, 2 were identified as most sensitive in identifying response to treatment. The identification of responder definitions for FM clinical trials that include assessments of key symptom and function domains may improve the sensitivity of clinical trials to identify meaningful improvements, leading to improved management of FM.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cella, D., Riley, W., Stone, A., Rothrock, N., Reeve, B., Yount, S., Amtmann, D., Bode, R., Buysse, D., Choi, S., et al. (2010) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.04.011 · Cited by 5,128
Dworkin, R. H., Turk, D. C., Wyrwich, K. W., Beaton, D., Cleeland, C. S., Farrar, J. T., Haythornthwaite, J. A., Jensen, M. P., Kerns, R. D., Ader, D. N., et al. (2008) · The Journal of Pain · doi:10.1016/j.jpain.2007.09.005 · Cited by 3,471 · cited 1×
“tant improvement in chronic pain disorders (36,37),”
The Revised Fibromyalgia Impact Questionnaire (FIQR): validation and psychometric properties
Bennett, R. M., Friend, R., Jones, K. D., Ward, R., Han, B. K., & Ross, R. L. (2009) · Arthritis Research & Therapy · doi:10.1186/ar2783 · Cited by 814
Treatment of fibromyalgia with antidepressants: A meta-analysis
O’Malley, P. G., Balden, E., Tomkins, G., Santoro, J., Kroenke, K., & Jackson, J. L. (2000) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.2000.06279.x · Cited by 340
Fibromyalgia Syndrome Module at OMERACT 9: Domain Construct
MEASE, P., ARNOLD, L. M., CHOY, E. H., CLAUW, D. J., CROFFORD, L. J., GLASS, J. M., MARTIN, S. A., MOREA, J., SIMON, L., STRAND, C. V., et al. (2009) · The Journal of Rheumatology · doi:10.3899/jrheum.090367 · Cited by 256
Self-citationUnderstanding fibromyalgia: lessons from the broader pain research community.
Williams, D. A., & Clauw, D. J. (2009) · The Journal of Pain · doi:10.1016/j.jpain.2009.06.001 · Cited by 250
Self-citationEstimation of minimum clinically important difference for pain in fibromyalgia
Mease, P. J., Spaeth, M., Clauw, D. J., Arnold, L. M., Bradley, L. A., Russell, I. J., Kajdasz, D. K., Walker, D. J., & Chappell, A. S. (2011) · Arthritis Care & Research · doi:10.1002/acr.20449 · Cited by 171
Self-citationBiology and therapy of fibromyalgia. New therapies in fibromyalgia.
Arnold (2006) · Arthritis Research & Therapy · doi:10.1186/ar1971 · Cited by 145 · cited 1×
“Recent trials have shown the efficacy of other medications for the treatment of FM, and continued development of new treatments is likely (8).”
CHOY, E. H., ARNOLD, L. M., CLAUW, D. J., CROFFORD, L. J., GLASS, J. M., SIMON, L. S., MARTIN, S. A., STRAND, C. V., WILLIAMS, D. A., & MEASE, P. J. (2009) · The Journal of Rheumatology · doi:10.3899/jrheum.090368 · Cited by 76
Self-citation
Cited by
AAPT Diagnostic Criteria for Fibromyalgia
Arnold, L. M., Bennett, R. M., Crofford, L. J., Dean, L. E., Clauw, D. J., Goldenberg, D. L., Fitzcharles, M.-A., Paiva, E. S., Staud, R., Sarzi-Puttini, P., et al. (2019) · The Journal of Pain · doi:10.1016/j.jpain.2018.10.008 · Cited by 420
Self-citationCognitive Impairment in Fibromyalgia
Bertolucci, P. H. F., & Oliveira, F. F. (2013) · Current Pain and Headache Reports · doi:10.1007/s11916-013-0344-9 · Cited by 62
Bidonde, J., Fisher, E., Perrot, S., Moore, R. A., Bell, R. F., Makri, S., & Häuser, W. (2023) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2023.152248 · Cited by 27
Paolucci, T., Baldari, C., Di Franco, M., Didona, D., Reis, V., Vetrano, M., Iosa, M., Trifoglio, D., Zangrando, F., Spadini, E., et al. (2016) · Evidence-Based Complementary and Alternative Medicine · doi:10.1155/2016/7574589 · Cited by 19
Metadata
- Authors
- Arnold, L. M., Williams, D. A., Hudson, J. I., Martin, S. A., Clauw, D. J., Crofford, L. J., Wang, F., Emir, B., Lai, C., Zablocki, R., & Mease, P. J.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 2012-02-28
- Volume
- 64
- Issue
- 3
- Pages
- 885-894
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2068946460
- Cited by
- 50
- References
- 9
- FWCI
- 1.77
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.